What you need to know to prepare for a conversation with your doctor, understand the diagnostic process, and manage your expectations. Everyone has aches and pains now and then. Most of us know what ...

Phase 3 trial data show that obinutuzumab significantly reduces disease activity in very active extrarenal lupus.

Lupus overwhelmingly affects women – we still don't know why – and while many people keep lupus in check through medication, about 5% of sufferers experience life-threatening complications. The ...

An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant ...

In the 13 th century, unusual skin lesions resembling wolf bites led to the term "lupus," meaning "wolf" in Latin. These symptoms also took the form of a butterfly across the face and to other parts ...

In his outstanding lecture identifying drivers of lupus, presented at the 2025 meeting of the Medical Dermatology Society, Jaehyuk Choi, MD, PhD, explained that interferon -- the well-known nemesis of ...

HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, allosteric small molecules that target natural regulatory pockets, today announced the ...